Circadian CLOCK-mediated regulation of target-tissue sensitivity to glucocorticoids

Implications for cardiometabolic diseases

Tomoshige Kino, George P. Chrousos

Research output: Chapter in Book/Report/Conference proceedingChapter

33 Citations (Scopus)

Abstract

Glucocorticoids, the end-products of the hypothalamic-pituitary-adrenal (HPA) axis, influence the functions of virtually all organs and tissues through the nuclear glucocorticoid receptor (GR). Circulating levels of glucocorticoids fluctuate naturally in a circadian fashion under the strong influence of the hypothalamic suprachiasmatic nucleus (SCN) circadian CLOCK system, and regulate the transcriptional activity of the GR in the brain and peripheral target tissues. We recently reported that the basic helix-loop-helix transcription factor Clock, which is a histone acetyltransferase and a central component of the self-oscillating transcription factor loop that generates circadian rhythms, represses GR transcriptional activity by acetylating lysine residues within the 'lysine cluster' located in the hinge region of the receptor. This Clock-mediated repression of GR transcriptional activity oscillates in inverse phase to the HPA axis, acting as a target tissue counter-regulatory mechanism to the diurnally fluctuating circulating glucocorticoids. Interestingly, mild evening elevations of cortisol, as occurs in chronic stress situations, and frequent uncoupling of the SCN CLOCK-directed HPA axis from the daily oscillation of target tissue sensitivity to glucocorticoids, as happens in trans-time zone travel and night shift work, produce functional hypercortisolism and, hence, multiple components of the metabolic syndrome with resultant cardiovascular complications.

Original languageEnglish
Title of host publicationPediatric Adrenal Diseases
PublisherS. Karger AG
Pages116-126
Number of pages11
Volume20
ISBN (Electronic)9783805596442
ISBN (Print)9783805596435
DOIs
Publication statusPublished - 17 Dec 2010
Externally publishedYes

Fingerprint

Glucocorticoid Receptors
Glucocorticoids
Tissue
Suprachiasmatic Nucleus
Lysine
Clocks
Basic Helix-Loop-Helix Transcription Factors
Histone Acetyltransferases
Cushing Syndrome
Hinges
Cytoplasmic and Nuclear Receptors
Circadian Rhythm
Hydrocortisone
Brain
Transcription Factors

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Circadian CLOCK-mediated regulation of target-tissue sensitivity to glucocorticoids : Implications for cardiometabolic diseases. / Kino, Tomoshige; Chrousos, George P.

Pediatric Adrenal Diseases. Vol. 20 S. Karger AG, 2010. p. 116-126.

Research output: Chapter in Book/Report/Conference proceedingChapter

@inbook{d786b1a8611f424c9f3b9e9eb2bc909b,
title = "Circadian CLOCK-mediated regulation of target-tissue sensitivity to glucocorticoids: Implications for cardiometabolic diseases",
abstract = "Glucocorticoids, the end-products of the hypothalamic-pituitary-adrenal (HPA) axis, influence the functions of virtually all organs and tissues through the nuclear glucocorticoid receptor (GR). Circulating levels of glucocorticoids fluctuate naturally in a circadian fashion under the strong influence of the hypothalamic suprachiasmatic nucleus (SCN) circadian CLOCK system, and regulate the transcriptional activity of the GR in the brain and peripheral target tissues. We recently reported that the basic helix-loop-helix transcription factor Clock, which is a histone acetyltransferase and a central component of the self-oscillating transcription factor loop that generates circadian rhythms, represses GR transcriptional activity by acetylating lysine residues within the 'lysine cluster' located in the hinge region of the receptor. This Clock-mediated repression of GR transcriptional activity oscillates in inverse phase to the HPA axis, acting as a target tissue counter-regulatory mechanism to the diurnally fluctuating circulating glucocorticoids. Interestingly, mild evening elevations of cortisol, as occurs in chronic stress situations, and frequent uncoupling of the SCN CLOCK-directed HPA axis from the daily oscillation of target tissue sensitivity to glucocorticoids, as happens in trans-time zone travel and night shift work, produce functional hypercortisolism and, hence, multiple components of the metabolic syndrome with resultant cardiovascular complications.",
author = "Tomoshige Kino and Chrousos, {George P.}",
year = "2010",
month = "12",
day = "17",
doi = "10.1159/000321232",
language = "English",
isbn = "9783805596435",
volume = "20",
pages = "116--126",
booktitle = "Pediatric Adrenal Diseases",
publisher = "S. Karger AG",
address = "Switzerland",

}

TY - CHAP

T1 - Circadian CLOCK-mediated regulation of target-tissue sensitivity to glucocorticoids

T2 - Implications for cardiometabolic diseases

AU - Kino, Tomoshige

AU - Chrousos, George P.

PY - 2010/12/17

Y1 - 2010/12/17

N2 - Glucocorticoids, the end-products of the hypothalamic-pituitary-adrenal (HPA) axis, influence the functions of virtually all organs and tissues through the nuclear glucocorticoid receptor (GR). Circulating levels of glucocorticoids fluctuate naturally in a circadian fashion under the strong influence of the hypothalamic suprachiasmatic nucleus (SCN) circadian CLOCK system, and regulate the transcriptional activity of the GR in the brain and peripheral target tissues. We recently reported that the basic helix-loop-helix transcription factor Clock, which is a histone acetyltransferase and a central component of the self-oscillating transcription factor loop that generates circadian rhythms, represses GR transcriptional activity by acetylating lysine residues within the 'lysine cluster' located in the hinge region of the receptor. This Clock-mediated repression of GR transcriptional activity oscillates in inverse phase to the HPA axis, acting as a target tissue counter-regulatory mechanism to the diurnally fluctuating circulating glucocorticoids. Interestingly, mild evening elevations of cortisol, as occurs in chronic stress situations, and frequent uncoupling of the SCN CLOCK-directed HPA axis from the daily oscillation of target tissue sensitivity to glucocorticoids, as happens in trans-time zone travel and night shift work, produce functional hypercortisolism and, hence, multiple components of the metabolic syndrome with resultant cardiovascular complications.

AB - Glucocorticoids, the end-products of the hypothalamic-pituitary-adrenal (HPA) axis, influence the functions of virtually all organs and tissues through the nuclear glucocorticoid receptor (GR). Circulating levels of glucocorticoids fluctuate naturally in a circadian fashion under the strong influence of the hypothalamic suprachiasmatic nucleus (SCN) circadian CLOCK system, and regulate the transcriptional activity of the GR in the brain and peripheral target tissues. We recently reported that the basic helix-loop-helix transcription factor Clock, which is a histone acetyltransferase and a central component of the self-oscillating transcription factor loop that generates circadian rhythms, represses GR transcriptional activity by acetylating lysine residues within the 'lysine cluster' located in the hinge region of the receptor. This Clock-mediated repression of GR transcriptional activity oscillates in inverse phase to the HPA axis, acting as a target tissue counter-regulatory mechanism to the diurnally fluctuating circulating glucocorticoids. Interestingly, mild evening elevations of cortisol, as occurs in chronic stress situations, and frequent uncoupling of the SCN CLOCK-directed HPA axis from the daily oscillation of target tissue sensitivity to glucocorticoids, as happens in trans-time zone travel and night shift work, produce functional hypercortisolism and, hence, multiple components of the metabolic syndrome with resultant cardiovascular complications.

UR - http://www.scopus.com/inward/record.url?scp=84926129068&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84926129068&partnerID=8YFLogxK

U2 - 10.1159/000321232

DO - 10.1159/000321232

M3 - Chapter

SN - 9783805596435

VL - 20

SP - 116

EP - 126

BT - Pediatric Adrenal Diseases

PB - S. Karger AG

ER -